TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31799796

Group type: EXPERIMENTAL
Intervention: Non-dedicated ventilator for MPV (PB560, Covidien) with a plastic angled mouthpiece
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dedicated MPV ventilator (Trilogy 100, Philips Respironics) without backup rate and kiss trigger combined with a silicone straw mouthpiece
Number of subjects: 20
Study: 30284454

Group type: EXPERIMENTAL
Intervention: Subjective social isolation
Number of subjects: 2541

Group type: EXPERIMENTAL
Intervention: Objective social isolation
Number of subjects: 2541
Study: 28922159

Group type: EXPERIMENTAL
Intervention: Singing Group (SG)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Painting Group (PG)
Number of subjects: 59
Study: 26360283

Group type: EXPERIMENTAL
Intervention: Bespoke smoking cessation strategy (behavioural support and drugs)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 97
Study: 24342651

Group type: EXPERIMENTAL
Intervention: Eravacycline at 1.5 mg/kg q24h
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Eravacycline at 1.0 mg/kg q12h
Number of subjects: 139

Group type: COMPARATOR
Intervention: Ertapenem at 1 g q24h
Number of subjects: 139
Study: 22964320

Group type: EXPERIMENTAL
Intervention: Fast track surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 70
Study: 19574947

Group type: EXPERIMENTAL
Intervention: Piribedil (50 mg for 90 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Piribedil
Number of subjects: 100
Study: 17306648

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - conjugated estrogens 0.625 mg plus medroxyprogesterone acetate 2.5 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 15105403

Group type: EXPERIMENTAL
Intervention: Promegetone 0.5 mg plus estradiol 2 mg (E) per day
Number of subjects: 78

Group type: COMPARATOR
Intervention: Promegetone 0.5 mg plus estradiol placebo (PL)
Number of subjects: 78
Study: 12880955

Group type: EXPERIMENTAL
Intervention: Screening for neuroblastoma at 1 year of age
Number of subjects: 2581188

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 2581188
Study: 9650542

Group type: EXPERIMENTAL
Intervention: Intravenous losartan
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral losartan
Number of subjects: 11
Study: 7544684

Group type: EXPERIMENTAL
Intervention: Hypertonic saline-dextran (HSD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no HSD)
Number of subjects: 20
Study: 2474257

Group type: EXPERIMENTAL
Intervention: 2 litres of crystalloid solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1 litre of colloid solution (hydroxyethyl starch)
Number of subjects: 60
Study: 591135

Group type: EXPERIMENTAL
Intervention: On-site urine testing (by the EMIT system) with immediate feedback of results to patients and staff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Off-site urine testing (by thin-layer chromatography)
Number of subjects: 0
Study: 31416496

Group type: EXPERIMENTAL
Intervention: Progressively integrated sandplay therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Structured teaching and auditory integration training (AIT)
Number of subjects: 50
Study: 28917373

Group type: EXPERIMENTAL
Intervention: Topical Rosa damascena oil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25970668

Group type: EXPERIMENTAL
Intervention: Breakfast Omission
Number of subjects: 10

Group type: COMPARATOR
Intervention: Breakfast Consumption
Number of subjects: 10
Study: 23506514

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program (CB; n = 166)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Nonspecific control (NSp; n = 175)
Number of subjects: 518

Group type: COMPARATOR
Intervention: No-intervention control (NIC; n = 177)
Number of subjects: 518
Study: 21451092

Group type: EXPERIMENTAL
Intervention: Various physical therapy interventions
Number of subjects: 42
Study: 19349712

Group type: EXPERIMENTAL
Intervention: TTS E2/MPA (transdermal estradiol 50 microg + oral medroxyprogesterone acetate 10 mg/day for 12 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 16690058

Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation and ICSI (in patients with unilateral or bilateral cystectomy)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation and ICSI (in patients with unilateral cystectomy)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (patients with tubal factor infertility)
Number of subjects: 156
Study: 14767865

Group type: EXPERIMENTAL
Intervention: Omacor (omega-3 polyunsaturated fatty acid concentrate) 4 capsules daily for 8 weeks
Number of subjects: 14
Study: 11244133

Group type: EXPERIMENTAL
Intervention: Gold sodium thiosulfate (0.5% in petrolatum)
Number of subjects: 4101
Study: 9260445

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (non-ADHD children)
Number of subjects: 12
Study: 8501418

Group type: EXPERIMENTAL
Intervention: Cyclosporin (Cs) treatment at an initial dose of 10 mg kg‐1 BW day‐1 for 12 months
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cyclosporin (Cs) treatment
Number of subjects: 105
Study: 3519096

Group type: EXPERIMENTAL
Intervention: Low-dose trimipramine (25 to 75 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 31618768

Group type: EXPERIMENTAL
Intervention: Acetic acid-targeted biopsies
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nontargeted biopsies (Seattle protocol)
Number of subjects: 200
Study: 30521639

Group type: EXPERIMENTAL
Intervention: NOACs (rivaroxaban, dabigatran, apixaban)
Number of subjects: 149180

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 149180

Group type: EXPERIMENTAL
Intervention: Total PBS anticoagulant expenditure
Number of subjects: 149180
Study: 29231566

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with autohemotherapy of acupoint injection
Number of subjects: 75

Group type: COMPARATOR
Intervention: Moxibustion
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 25301344

Group type: EXPERIMENTAL
Intervention: Piperacillin 4 g with tazobactam 0.5 g intravenously by 1-hour infusion every 8 hours
Number of subjects: 3
Study: 22735756

Group type: EXPERIMENTAL
Intervention: RC-3095 (3 mg/kg, intravenous) administered over a period of 12 h in human patients with sepsis.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RC-3095 (3 mg/kg, subcutaneously) in male Wistar rats subjected to cecal ligation and puncture (CLP).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RC-3095 (10 ng/mL) in RAW 264.7 culture cells exposed to LPS or TNF-α.
Number of subjects: 0
Study: 15986192

Group type: EXPERIMENTAL
Intervention: 0.42 mg/kg d,l-dexamphetamine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.42 mg/kg d-methamphetamine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.42 mg/kg d,l-methamphetamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11929743

Group type: EXPERIMENTAL
Intervention: High-intensity group intervention including home assessments, individualized action plans, education, social support, and materials to reduce exposures over 12 months
Number of subjects: 274

Group type: COMPARATOR
Intervention: Low-intensity group intervention including initial assessment, home action plan, limited education, and bedding encasements
Number of subjects: 274
Study: 9588402

Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 40

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 40
Study: 8535711

Group type: EXPERIMENTAL
Intervention: 50 mg epirubicin combined with 10 MU alpha 2b‐IFN, intravesically in 50 mL sterile buffer solution
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 50 mg epirubicin
Number of subjects: 81

Group type: COMPARATOR
Intervention: Transurethral resection (TUR) alone
Number of subjects: 81
Study: 2243428

Group type: EXPERIMENTAL
Intervention: Combined drug regimens and diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 347042

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Escherichia coli K100
Number of subjects: 85
Study: 30458740

Group type: EXPERIMENTAL
Intervention: Bitterant formulation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Perfumed formulation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Plain formulation
Number of subjects: 43
Study: 27585777

Group type: EXPERIMENTAL
Intervention: GC Tooth Mousse
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Clinpro 5000
Number of subjects: 44

Group type: COMPARATOR
Intervention: 50-ppm sodium fluoride solution
Number of subjects: 44

Group type: COMPARATOR
Intervention: Artificial saliva
Number of subjects: 44
Study: 26217423

Group type: EXPERIMENTAL
Intervention: Online SBIRT training
Number of subjects: 40

Group type: COMPARATOR
Intervention: In-person SBIRT training
Number of subjects: 40
Study: 23724518

Group type: EXPERIMENTAL
Intervention: Gonadotropin treatment and letrozole along with GnRH antagonist protocol (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gonadotropin treatment along with GnRH antagonist protocol (Group 2)
Number of subjects: 50
Study: 21036071

Group type: EXPERIMENTAL
Intervention: Moderated journal club
Number of subjects: 443

Group type: COMPARATOR
Intervention: Internet journal club
Number of subjects: 443
Study: 18721002

Group type: EXPERIMENTAL
Intervention: Cinacalcet 90 mg once daily for 5 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Midazolam 2 mg alone
Number of subjects: 12
Study: 17345916

Group type: EXPERIMENTAL
Intervention: MI with feedback
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: MI without feedback
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Mailed feedback only
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: MI with mailed feedback
Number of subjects: 122

Group type: COMPARATOR
Intervention: Assessment only control
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Feedback (for females)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: MI (for females)
Number of subjects: 122
Study: 12590890

Group type: EXPERIMENTAL
Intervention: QuicKlamp mechanical compression
Number of subjects: 100

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 100
Study: 11196006

Group type: EXPERIMENTAL
Intervention: High expressed emotion (EE) relatives during family problem-solving interactions
Number of subjects: 47

Group type: COMPARATOR
Intervention: Low expressed emotion (EE) relatives during family problem-solving interactions
Number of subjects: 47
Study: 8824967

Group type: EXPERIMENTAL
Intervention: Single injection of diphtheria and tetanus toxoids and pertussis vaccine combined with inactivated poliovirus vaccine
Number of subjects: 84
Study: 1486543

Group type: EXPERIMENTAL
Intervention: Pravastatin (hydroxymethyl glutaryl coenzyme A reductase inhibitor)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Medical management only
Number of subjects: 600

Group type: COMPARATOR
Intervention: Coronary bypass graft
Number of subjects: 600

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 600
Study: 3976552

Group type: EXPERIMENTAL
Intervention: Protein-sparing-modified fast (PSMF)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Protein-formula-liquid diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both conditions (PSMF and liquid diet)
Number of subjects: 16
Study: 30860948

Group type: EXPERIMENTAL
Intervention: AS + RT + CT
Number of subjects: 612

Group type: COMPARATOR
Intervention: AS + RT
Number of subjects: 612
Study: 29910009

Group type: EXPERIMENTAL
Intervention: Lofexidine (n=56)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Diazepam (n=55)
Number of subjects: 111
Study: 26877078

Group type: EXPERIMENTAL
Intervention: Web-based training (30 minutes, 6 days per week for 20 weeks)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care (waitlist control)
Number of subjects: 101
Study: 25278376

Group type: EXPERIMENTAL
Intervention: Once-daily extended-release tacrolimus (LCPT)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Twice-daily tacrolimus
Number of subjects: 543
Study: 22639400

Group type: EXPERIMENTAL
Intervention: rhPTH (1-34)
Number of subjects: 124

Group type: COMPARATOR
Intervention: elcatonin
Number of subjects: 124
Study: 20143651

Group type: EXPERIMENTAL
Intervention: Rupatadine, 20 mg/d
Number of subjects: 21
Study: 18982785

Group type: EXPERIMENTAL
Intervention: Digital nerve block in the middle finger of the left hand
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study: 16087838

Group type: EXPERIMENTAL
Intervention: Pupil ovalization after phakic intraocular lens implantation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regular pupils (control group)
Number of subjects: 12
Study: 12585164

Group type: EXPERIMENTAL
Intervention: Jiangzhi Tiaoya Granule (JZTYG)
Number of subjects: 59
Study: 10506719

Group type: EXPERIMENTAL
Intervention: Older urologists
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Younger urologists
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Urologist age
Number of subjects: 1050
Study: 7503601

Group type: EXPERIMENTAL
Intervention: Low-dose amphotericin B (total dose ≤ 500 mg)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: High-dose amphotericin B (total dose > 500 mg)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 427

Group type: COMPARATOR
Intervention: Catheter-related candidemia (catheters retained)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Catheter-related candidemia (catheters removed)
Number of subjects: 427
Study: 2048709

Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg/kg i.v. given at induction of anesthesia after intubation (n = 20)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg/kg i.v. given during the last muscle suture (n = 21)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No antiemetic treatment (n = 20)
Number of subjects: 61
Study: 6793303

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of prostaglandin F2 alpha (PGF2 alpha)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral quinine hydrochloride
Number of subjects: 200
Study: 31391029

Group type: EXPERIMENTAL
Intervention: iCBT intervention consisting of six modules over 9 weeks
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 1050
Study: 28867441

Group type: EXPERIMENTAL
Intervention: #standwithpp
Number of subjects: 30000

Group type: COMPARATOR
Intervention: #defundpp
Number of subjects: 30000

Group type: COMPARATOR
Intervention: #standwithpp and #defundpp
Number of subjects: 30000
Study: 25553558

Group type: EXPERIMENTAL
Intervention: Intervention group (Transtheoretical Model workshops)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (physical activity and open group-education regarding nutrition of usual care)
Number of subjects: 71
Study: 24086259

Group type: EXPERIMENTAL
Intervention: PCV-7 (wholly vaccinated villages)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Serogroup-C-meningococcal-conjugate-vaccine (partly vaccinated villages)
Number of subjects: 16
Study: 21884603

Group type: EXPERIMENTAL
Intervention: Child-based intervention: Unstructured materials with no obvious play value introduced to the playground
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Adult-based intervention: Risk reframing sessions held with parents and teachers
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group: Schools have recess as usual
Number of subjects: 216
Study: 19694438

Group type: EXPERIMENTAL
Intervention: Yerba mate consumption (330 mL, 3 times/day for 40 days) in normolipidemic subjects
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Yerba mate intake by dyslipidemic individuals (330 mL, 3 times/day for 40 days)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Yerba mate consumption by hypercholesterolemic individuals on statin therapy (330 mL, 3 times/day for 40 days)
Number of subjects: 102
Study: 17240472

Group type: EXPERIMENTAL
Intervention: Telmisartan (20-40mg orally once daily for 6 months)
Number of subjects: 36
Study: 15616203

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 4047

Group type: COMPARATOR
Intervention: Control group (conventionally treated obese subjects)
Number of subjects: 4047
Study: 11495267

Group type: EXPERIMENTAL
Intervention: Nested PCR
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Smear
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Culture
Number of subjects: 90
Study: 9708408

Group type: EXPERIMENTAL
Intervention: C4-V3 PV immunogen
Number of subjects: 10

Group type: COMPARATOR
Intervention: Incomplete Freund's adjuvant
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: C4-V3 PV immunogen and Incomplete Freund's adjuvant
Number of subjects: 10
Study: 7568694

Group type: EXPERIMENTAL
Intervention: No incision (test)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard incision (control)
Number of subjects: 11
Study: 3267741

Group type: EXPERIMENTAL
Intervention: Group therapy (10 sessions of 90 minutes each, led by a psychologist and a general practitioner)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 31868550

Group type: EXPERIMENTAL
Intervention: 0.25ug alfacalcidol daily for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30851986

Group type: EXPERIMENTAL
Intervention: Beck Scale for Suicidal Ideation (BSI)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Beck Hopelessness Scale (BHS)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Suicide Attempt Self Injury Interview (SASII)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Pesticide and insecticide use
Number of subjects: 221
Study: 29325436

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Schema Therapy
Number of subjects: 100
Study: 27482783

Group type: EXPERIMENTAL
Intervention: Test implant
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control implant
Number of subjects: 57
Study: 25451897

Group type: EXPERIMENTAL
Intervention: Bolus advisors
Number of subjects: 42
Study: 22592546

Group type: EXPERIMENTAL
Intervention: Swimming at 2.5% below RCP (S - 2.5%)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Swimming at 2.5% above RCP (S + 2.5%)
Number of subjects: 9
Study: 20919669

Group type: EXPERIMENTAL
Intervention: Subcutaneous closed-suction drainage (SCSD) applied after fascia closure, removed on postoperative day three.
Number of subjects: 402

Group type: COMPARATOR
Intervention: No subcutaneous closed-suction drainage (no-drain group).
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for patients with drains who underwent resection of colorectal malignancies or had lower abdominal incisions.
Number of subjects: 402
Study: 17592906

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 400 mg/day
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 600 mg/day
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 800 mg/day
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Quetiapine IR 400 mg/day
Number of subjects: 588

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 588
Study: 16157416

Group type: EXPERIMENTAL
Intervention: Morning exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Evening exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morning control
Number of subjects: 12

Group type: COMPARATOR
Intervention: Evening control
Number of subjects: 12
Study: 11430779

Group type: EXPERIMENTAL
Intervention: Vitamin B complex dietary intake
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Vitamin B complex status
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Dietary intake and status relationship
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Preventive multivitamin supplementation
Number of subjects: 141
Study: 9216965

Group type: EXPERIMENTAL
Intervention: Isotonic carbohydrate‐electrolyte beverage (CHO‐E)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Water placebo (WP)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Comparison of WP and CHO‐E
Number of subjects: 7
Study: 8423261

Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacing of 0.75, 1.0, 1.25, 1.5, and 2 ERB, central component frequency of 1000 Hz, level of 65 dB SPL.
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacing of 0.75 ERB.
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacing increased from 1 to 2 ERBs.
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacings of 1.25 or less.
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Complex tone with component frequencies above 1000 Hz.
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Complex tone with component frequencies below 1000 Hz.
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Auditory filter shapes measured using the notched noise method.
Number of subjects: 4
Study: 2821864

Group type: EXPERIMENTAL
Intervention: Ritodrine treatment (intravenous, 2 hours prior to operation)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Physiological saline (control group, same infusion rate as ritodrine)
Number of subjects: 15
Study: 2663239

Group type: EXPERIMENTAL
Intervention: Ketanserin, 80 mg/day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ketanserin plus Metoprolol
Number of subjects: 34

Group type: COMPARATOR
Intervention: Metoprolol, 200 mg/day
Number of subjects: 34
Study: 31380892

Group type: EXPERIMENTAL
Intervention: Professional coaching intervention (6 coaching sessions)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 88